BridgeMD
Compares treatment options for ST Elevation Myocardial Infarction
Official title Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
ClinicalTrials.gov ID: NCT06353594
What this study is testing
- What it's testing
- The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI). Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \- Patients presenting with STEMI and indication to undergo pPCI.
You likely can't join if
- Life expectancy \<1 year due 1 to non-cardiac disease.
- Inability to provide informed consent.
- Cardiogenic shock.
- Left ventricular ejection fraction \<15%.
- Left main disease.
- Stent thrombosis
See the full eligibility criteria
- \- Patients presenting with STEMI and indication to undergo pPCI.
- Life expectancy \<1 year due 1 to non-cardiac disease.
- Inability to provide informed consent.
- Cardiogenic shock.
- Left ventricular ejection fraction \<15%.
- Left main disease.
- Stent thrombosis
- Patients with prior bypass graft lesions requiring PCI (culprit or non culprit lesions).
- Patients with chronic total occlusions.
- Untreatable coronary disease.
- Non-identified culprit lesion.
- Known allergy to aspirin, ticagrelor, prasugrel, clopidogrel, paclitaxel or sirolimus.
The study team makes the final eligibility decision.
Where it's taking place
- Huelva, Huelva, Spain
- Valencia, Valencia, Spain
- A Coruña, Spain
- Burgos, Spain
- Castelló, Spain
- Córdoba, Spain
- Elche, Spain
- Granada, Spain
- L'Hospitalet de Llobregat, Spain
- Madrid, Spain
- Málaga, Spain
- Mérida, Spain
- Pamplona, Spain
- Santiago de Compostela, Spain
- Seville, Spain
- Tarragona, Spain
- Terrassa, Spain
- Valencia, Spain
- Valladolid, Spain
- Zaragoza, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huelva, Huelva, Spain; Valencia, Valencia, Spain; A Coruña, Spain; Burgos, Spain; Castelló, Spain; Córdoba, Spain and 14 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.